Document is current
Any future updates will be listed below
-
Authors
Yuda, Junichiro https://orcid.org/0000-0002-4908-1636
Wang, Chaochen https://orcid.org/0000-0001-5533-1497
Terasawa, Tomoko
Tajimi, Masaomi https://orcid.org/0000-0001-5815-377X
Osaga, Satoshi
Miura, Moemi https://orcid.org/0009-0007-8632-9294
Takaoka, Shori https://orcid.org/0009-0008-3495-6963
Tanizawa, Yoshinori https://orcid.org/0000-0002-5014-2483
- License Information
-
More Information
Article History
Received: 16 July 2024
Accepted: 5 October 2024
First Online: 21 October 2024
Declarations
:
: Junichiro Yuda received research funds from AbbVie GK, Daiichi Sankyo Co. Ltd., Chugai Pharmaceutical Co., Ltd., Genmab K.K., Novartis Pharma K.K., Amgen K.K., Takeda Pharmaceutical Co. Ltd., Bristol-Myers Squibb K.K., Incyte Biosciences Japan G.K., Janssen Pharmaceutical K.K., Sumitomo Pharma Co., Ltd., MSD K.K., and Mitsubishi Tanabe Pharma Corporation. Chaochen Wang, Tomoko Terasawa, Masaomi Tajimi, Satoshi Osaga, and Yoshinori Tanizawa are employed full-time by Eli Lilly Japan K.K. and are minor stockholders of Eli Lilly and Company. Moemi Miura and Shori Takaoka are full-time employees of Social Survey Research Information Co., Ltd.
